Clinical trial
A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
NCT02594254 is registered in ClinicalTrials.gov with Armata Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Double-Blind, Placebo-Controlled and Open-Label Multi-Center Study to Evaluate the Microbiology and Safety of C16G2 Administered in Multiple Oral Gel Doses to Adult and Adolescent Dental Subjects
- Lead sponsor
- Armata Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- September 30, 2016
- Enrollment
- 135 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.